Generex Biotechnology (GNBT) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Generex Biotechnology Short Interest DataGenerex Biotechnology (GNBT) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 60,924 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.06Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2022Outstanding Shares122,058,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume60,924 sharesToday's Volume Vs. Average0% Short Selling Generex Biotechnology? Sign up to receive the latest short interest report for Generex Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNBT Short Interest Over TimeGNBT Days to Cover Over TimeGNBT Percentage of Float Shorted Over Time Generex Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2022100 shares $0.06 No ChangeN/A0 $0.00 9/30/2022100 shares $0.07 No ChangeN/A0 $0.00 9/15/2022100 shares $0.08 No ChangeN/A0 $0.00 8/31/2022100 shares $0.07 No ChangeN/A0 $0.00 8/15/2022100 shares $0.10 No ChangeN/A0 $0.00 7/31/2022100 shares $0.15 No ChangeN/A0 $0.00 7/15/2022100 shares $0.49 No ChangeN/A0 $0.00 6/30/2022100 shares $0.06 No ChangeN/A0 $0.00 6/15/2022100 shares $0.06 No ChangeN/A0 $0.00 5/31/2022100 shares $0.19 No ChangeN/A0 $0.00 Get the Latest News and Ratings for GNBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Generex Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 5/15/2022100 shares $0.19 No ChangeN/A0 $0.00 4/30/2022100 shares $0.22 No ChangeN/A0 $0.00 4/15/2022100 shares $0.50 No ChangeN/A0 $0.01 3/31/2022100 shares $0.48 No ChangeN/A0 $0.00 3/15/2022100 shares $0.12 No ChangeN/A0 $0.00 2/28/2022100 shares $0.50 -99.8%N/A0 $0.01 2/15/202244,400 shares $2.93 thousand +44,300.0%N/A0.1 $0.07 1/31/2022100 shares $4.75 No ChangeN/A0 $0.05 1/15/2022100 shares $5.63 -99.5%N/A0 $0.06 12/31/202120,000 shares $1.24 thousand -43.7%N/A0 $0.06 12/15/202135,500 shares $2.84 thousand +393.1%N/A0 $0.08 11/30/20217,200 shares $860.40 -88.1%N/A0 $0.12 11/15/202160,600 shares $6.36 thousand +551.6%N/A0.1 $0.11 10/29/20219,300 shares $1.37 thousand -95.7%N/A0 $0.15 10/15/2021216,000 shares $35.99 thousand -3.0%N/A0.5 $0.17 9/30/2021222,700 shares $42.71 thousand +0.4%N/A0.5 $0.19 9/15/2021221,800 shares $39.88 thousand -3.9%N/A0.4 $0.18 8/31/2021230,900 shares $49.62 thousand +13.9%N/A0.5 $0.21 8/13/2021202,800 shares $41.57 thousand -1.6%N/A0.5 $0.21 7/30/2021206,000 shares $48.77 thousand -1.2%N/A0.5 $0.24 7/15/2021208,500 shares $49.25 thousand -5.1%N/A0.8 $0.24 6/30/2021219,600 shares $54.90 thousand -5.6%N/A0.4 $0.25 6/15/2021232,500 shares $55.29 thousand +8.9%N/A0.4 $0.24 5/28/2021213,500 shares $59.78 thousand -10.1%N/A0.6 $0.28 5/14/2021237,400 shares $65.33 thousand +13.9%N/A0.5 $0.28 4/30/2021208,500 shares $56.30 thousand -6.9%N/A0.5 $0.27 4/15/2021223,900 shares $58.77 thousand +4.9%N/A0.3 $0.26 3/31/2021213,500 shares $61.85 thousand -4.6%N/A0.4 $0.29 3/15/2021223,700 shares $85.01 thousand +1.7%N/A0.2 $0.38 2/26/2021219,900 shares $95.66 thousand -4.0%N/A0.2 $0.44The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 2/12/2021229,100 shares $98.54 thousand -36.0%N/A0.1 $0.43 1/29/2021358,200 shares $161.19 thousand -13.8%N/A0.2 $0.45 1/15/2021202,800 shares $62.20 thousand -36.7%N/A0.4 $0.31 12/31/2020204,600 shares $37.78 thousand +0.9%N/A0.2 $0.18 12/15/2020202,800 shares $44.01 thousand -36.7%N/A0.4 $0.22 11/30/2020320,600 shares $70.53 thousand +32.0%N/A0.2 $0.22 11/15/2020242,900 shares $48.31 thousand -44.9%N/A0.1 $0.20 10/30/2020440,400 shares $87.55 thousand -3.0%N/A0.6 $0.20 10/15/2020453,900 shares $110.30 thousand -15.9%N/A0.3 $0.24 9/30/2020539,600 shares $122.71 thousand -2.2%N/A0.2 $0.23 9/15/2020551,800 shares $163.83 thousand +35.0%N/A0.6 $0.30 8/31/2020408,800 shares $154.53 thousand +95.0%N/A0.3 $0.38 8/14/2020209,600 shares $88.03 thousand -7.2%N/A0.2 $0.42 7/31/2020225,900 shares $115.21 thousand -20.7%N/A0.2 $0.51 7/15/2020284,700 shares $162.28 thousand -12.3%N/A0.5 $0.57 GNBT Short Interest - Frequently Asked Questions What is Generex Biotechnology's current short interest? Short interest is the volume of Generex Biotechnology shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 100 shares of GNBT short. Learn More on Generex Biotechnology's current short interest. How does Generex Biotechnology's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Generex Biotechnology: TC Biopharm (Holdings) Plc (176.43%), Bon Natural Life Limited (51.46%), Capstone Holding Corp. (0.11%), Vincerx Pharma, Inc. (0.05%), Smart for Life, Inc. (0.01%), Propanc Biopharma Inc (1.58%), Neptune Wellness Solutions Inc. (1.19%), Navidea Biopharmaceuticals, Inc. (0.00%), Optec International, Inc. (0.00%), Scopus BioPharma Inc. (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($3.48 billion), Charter Communications, Inc. ($2.85 billion), Twitter, Inc. ($1.89 billion), T. Rowe Price Group, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.77 billion), Pacific Gas & Electric Co. ($1.75 billion), Lucid Group, Inc. ($1.58 billion), Rivian Automotive, Inc. ($1.42 billion), Roblox Corporation ($1.39 billion), and Williams-Sonoma, Inc. ($1.33 billion). View all of the most shorted stocks. What does it mean to sell short Generex Biotechnology stock? Short selling GNBT is an investing strategy that aims to generate trading profit from Generex Biotechnology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Generex Biotechnology? A short squeeze for Generex Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNBT, which in turn drives the price of the stock up even further. How often is Generex Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNBT, twice per month. The most recent reporting period available is October, 15 2022. More Short Interest Resources from MarketBeat Related Companies TCBP Short Squeeze BON Short Squeeze CAPS Short Squeeze VINC Short Squeeze SMFL Short Squeeze PPCB Short Squeeze NEPTF Short Squeeze NAVB Short Squeeze OPTI Short Squeeze SCPS Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GNBT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generex Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generex Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
